Hyperbilirubinemia is one of the most common clinical phenomena in the neonatal patient. The etiology is generally physiological, only about 10% being pathological. It is essential for clinicians to distinguish between physiological and pathological hyperbilirubinemia, because uncontrolled pathological conditions can cause severe complications of kern icterus, one of the causes of death in infants. This study was aimed to know the level of hemoglobin and leukocyte count in neonates with hyperbilirubinemia in the Dr. Wahidin Sudirohusodo Hospital, Makassar. This study was a retrospective by obtaining data of all neonatal patients with a diagnosis of hyperbilirubinemia, who underwent hemoglobin and leukocyte count test. The data were classified into two groups: physiological and pathological hyperbilirubinemia. Statistical tests were performed to assess the association of hemoglobin levels and leukocytes count between the two groups. A total of 144 data were collected, 54 physiological and 90 pathological hyperbilirubinemia. In physiological hyperbilirubinemia, hemoglobin levels and leukocyte counts were found to be normal, whereas in pathological hyperbilirubinemia, anemia and leukocytosis developed and the difference between the two groups was statistically significant (p<0.001). Anemia was found in neonates with pathological hyperbilirubinemia caused by Respitarory Distress of Newborn (RDN), Low Birth Weight (LBW), sepsis, hemolytic, and hemorrhagic. Leukocytosis was found in pathological hyperbilirubinemia caused by sepsis. There was a significant difference between the incidence of anemia and leukocytosis in physiological and pathological hyperbilirubinemia. It can be concluded that routine blood tests can be used to distinguish whether hyperbilirubinemia experienced by a neonatal patient is a physiological or pathological condition, so that it can be one of the tests suggested when the neonate has hyperbilirubinemia.
INTRODUCTION
Hyperbilirubinemia is one of the most common clinical phenomena in neonates. The incidence of hyperbilirubinemia is quite high and increasing. Data in the United States showed that, from 4 million n e w b o r n s e a c h y e a r , a b o u t 6 5 % h a v e hyperbilirubinemia. Existing epidemiological data suggest that over 50% of newborns develop clinically detectable hyperbilirubinemia within the first week [1] [2] [3] of birth. Hyperbilirubinemia in neonates is a condition with increased bilirubin and is characterized by icterus or jaundice. Jaundice in neonates will be visible when the total bilirubin level is > 5 mg/dL (>85 μmol/L). Icterus or jaundice occurs due to the accumulation of bilirubin in the blood so [1] [2] [3] [4] [5] [6] that the skin and sclera appear yellowish.
Most of the hyperbilirubinemia in neonates is normal (physiological), only about 10% is pathological. Etiology of pathological hyperbilirubinemia include hemolytic disease, prematurity, Low Birth Weight (LBW), asphyxia, respiratory disease, hemorrhagic, and systemic infection (neonatal sepsis). It is crucial for the clinician to distinguish between them because uncontrolled pathological hyperbilirubinemia and poor management can lead to kernicterus, a severe [1] [2] [3] [4] [5] complication leading to death in infants.
Separating physiological from pathological hyperbilirubinemia can be done by considering the gestational age, clinical symptoms, and bilirubin level. The characteristics of physiologic hyperbilirubinemia are occurring on day 2-3, total bilirubin level <12 mg/dL in full-term neonates and <10 mg/dL in preterm neonates, rate of bilirubin level elevation<5 mg/dL/day, direct bilirubin level <1 mg/dL, cessation of jaundice in the first ten days of life, and no proven related pathological condition. Pathologic hyperbilirubinemia characteristics include jaundice occurring in the first twenty-four hours of life, total bilirubin>12 mg/dL in full-term and >10 mg/dL in preterm neonates, rate of bilirubin elevation >5 mg/dL/day, direct bilirubin level >1 mg/dL, persistent jaundice after the first two weeks, and known related pathologic conditions, such as hemolytic disease, infections or other 1, [3] [4] [5] [6] [7] pathologic conditions. Mishra et al. stated that there were differences in hemoglobin levels and leukocyte count in physiological and pathological hyperbilirubinemia. Neonates with physiological hyperbilirubinemia were reported to have normal hemoglobin and leukocyte count, while neonates with pathological hyperbilirubinemia had anemia, reticulocytosis, and leukocytosis. Shah et al. also mentioned that anemia was commonly found in neonates with pathological 6, 7 hyperbilirubinemia. The lifespan of erythrocytes in neonates is shorter (70-90 days) than adults (120 days). It leads to the increase of bilirubin levels in neonates (physiological). The physiological hyperbilirubinemia does not affect hemoglobin levels and leukocyte count in neonates. The mechanisms of anemia and leukocytosis in pathological hyperbilirubinemia are 1, 2, [5] [6] [7] [8] associated with its etiology.
Study on hemoglobin levels and leukocyte count in neonates with hyperbilirubinemia, to our knowledge, has never been done in Indonesia, especially in Makassar. Based on the background, the researchers wanted to know the level of hemoglobin a n d l e u k o c y t e c o u n t i n n e o n a t e s w i t h hyperbilirubinemia in the Dr. Wahidin Sudirohusodo Hospital, Makassar.
METHODS
This study was a retrospective study, with the study population being data of all neonates with a clinical diagnosis of hyperbilirubinemia treated in the children's department of the Dr. Wahidin Sudirohusodo Hospital Makassar. Sample collection was done by taking data from the medical record of neonates with a clinical diagnosis of hyperbilirubinemia from January 2016 -December 2016 in the Dr. Wahidin Sudirohusodo Hospital.
The study samples were all sample population tested for hemoglobin levels and leukocyte counts. Samples were classified into two groups: physiological and pathological hyperbilirubinemia. Hemoglobin levels and leukocyte counts were obtained from routine blood tests tested using an automatic hematology analyzer (Sysmex XN 1000, Japan). 
RESULTS AND DISCUSSION
Data from 144 neonates with hyperbilirubinemia was obtained, with characteristics as shown in Table 1 . Sex distribution in this study was consistent with the results of Shah et al. and Ramadevi et al., who reported that hyperbilirubinemia was more common in males (> 50%) compared to females (<40%). Mishra et al. reported a different result stating that the prevalence of hyperbilirubinemia was equal in males and females. As far as knowledge, there was no literature and research mentioning the 6, 7, 9 influence of sex on hyperbilirubinemia. This study showed that hyperbilirubinemia was more prevalent in the group of patients aged 0-1 day, which was 99 subjects (69.5%). Shah et days in preterm neonates. Table 1 showed that hyperbilirubinemia was more common in preterm (54.9%) than full-term neonates (45.1%). A previousstudy by Payal et al. and Kumar et al. showed a similar result. The risk of hyperbilirubinemia in preterm infants is higher due to an impaired liver function which causes inhibition in bilirubin excretion and results in bilirubin accumulation in the circulation and bilirubin [1] [2] [3] [4] [5] 8, [10] [11] deposition in the tissue. Table 1 also showed the incidence of physiological hyperbilirubinemia of 3 7 . 5 % . T h e m o s t c o m m o n p a t h o l o g i c a l hyperbilirubinemia etiology was RDN in 36 subjects (25%) followed by LBW in 27 subjects (18.7%) and sepsis in 25 subjects (17.4%). Short erythrocyte lifespan causes a high rate of erythrocyte destruction (hemolysis) resulting in increased bilirubin production. This mechanism causes physiological hyperbilirubinemia in the neonates. This mechanism also occurs in pathological hyperbilirubinemia due to hemolytic and hemorrhagic causes which results [1] [2] [3] [4] [5] 8 in increased bilirubin production.
A study by Syamsir et al. stated that elevated bilirubin levels might be due to sepsis. Various studies had concluded that sepsis might cause liver dysfunction, leading to inhibition of bilirubin 12 excretion. The mechanism of hyperbilirubinemia in LBW is caused by impaired liver function, causing inhibition in bilirubin excretion which results inbilirubin accumulation in the circulation and bilirubin deposition in the tissue. In RDN, hyperbilirubinemia occurs due to disruption of protein and bilirubin bonds as a result of hypoxia or [1] [2] [3] 5 acidosis.
From a total of 144 data, the mean of hemoglobin level in physiological hyperbilirubinemia was 17.94 g/dL±1.32 g/dL. The mean value of hemoglobin level in pathological hyperbilirubinemia was 13.75 g/dL ±1.94 g/dL. The mean value of leukocyte count in physiological hyperbilirubinemia was 11.92 g/dL ±2.67 g/dL, whereas in pathological hyperbilirubinemia the mean value was 17.79 g/dL ±9.09 g/dL ( Table 2) .
Classifying the samples as anemia and normal was based on data of hemoglobin levels, using the neonatal hemoglobin reference value. Further analysis of the incidence of anemia was performed in the two groups, and anemia was found in 84 subjects ( o u t o f 9 0 s u b j e c t s ) w i t h p a t h o l o g i c a l hyperbilirubinemia, while in physiological hyperbilirubinemia, only two subjects had anemia out of the total of 54 subjects. Chi-Square test showed that there was a significant difference between the incidence of anemia in physiological and pathological hyperbilirubinemia with a p-value <0.001 (Table 3) .
Shah et al. and Misrah et al., obtained similar results, although the pathological hyperbilirubinemia etiology was slightly different from our results. Physiological hyperbilirubinemia did not affect hemoglobin levels in neonates, so that hemoglobin levels were found within normal limits. This study showed that anemia occurred in pathological hyperbilirubinemia caused by RDN, sepsis, hemolytic 1, 2, [6] [7] and hemorrhagic.
The causes of anemia in the neonates can be classified into three mechanisms; blood loss increased erythrocyte destruction and decreased erythrocyte production. Anemia in pathological hyperbilirubinemia due to hemolysis and sepsis is caused by increased erythrocyte destruction, while anemia in hyperbilirubinemia due to RDN occurs as a result of decreased erythrocyte production. Blood loss is the cause of anemia in hyperbilirubinemia due 1, [5] [6] [7] [8] 13 to hemorrhagic disease.
Based on the data of leukocyte count, the sample was divided into two groups; leukocytosis and normal. The incidence of leukocytosis in physiological and pathological hyperbilirubinemia was analyzed statistically. The results showed no leukocytosis was found in physiological hyperbilirubinemia, while in pathological hyperbilirubinemia was found 23 out of 90 subjects had leukocytosis. Fisher Exact test was performed to assess the association of leukocytosis with hyperbilirubinemia and found significant differences between leukocytosis incidence in physiological and pathological hyperbilirubinemia with a p-value <0.001 ( Table 4) .
The results of this study were consistent with the Mishra et al. who mentioned that leukocytosis occurred in pathological hyperbilirubinemia due to sepsis. Leukocytosis in neonatal sepsis results from the interaction of complex responses between pathogenic microorganisms and hyperinflammatory 6 states.
CONCLUSION AND SUGGESTION
There was a significant difference between the incidence of anemia and leukocytosis in physiological and pathological hyperbilirubinemia ( p < 0 . 0 0 1 ) . N e o n a t e s w i t h p a t h o l o g i c a l hyperbilirubinemia due to RDN, LBW, sepsis, hemolytic, and hemorrhagic had anemia, whereas neonates with physiological hyperbilirubinemia had normal hemoglobin levels. Leukocyte count in pathological hyperbilirubinemia was found to be elevated, but not in physiological hyperbilirubinemia. In this study, leukocytosis was found in pathological hyperbilirubinemia due to sepsis.
From the results of this study, it can be concluded that routine blood tests can be used to distinguish whether hyperbilirubinemia in neonates is a physiological or pathological condition. This test can be one of the tests suggested evaluating neonates with hyperbilirubinemia, so that diagnosis and therapy can be more targeted and severe complications can be prevented.
